专利检索 ap:("JIAN LIU" OR "JOSEPH A. KOZLOWSKI" OR "ABDUL-BASIT ALHASSAN" OR "SOBHANA BABU BOGA" OR "XIAOLEI GAO" OR "DEODIAL GUY GUIADEEN" OR "JYHSHING WANG" OR "WENSHENG YU" OR "JIAQIANG CAI" OR "SHILAN LIU" OR "DAHAI WANG" OR "HAO WU" OR "CHUNDAO YANG") AND inv:"ABDUL-BASIT ALHASSAN" 第 1 页

1.

发明申请
BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS 审中-公开

公开(公告)号：US20170362242A1

公开(公告)日：2017-12-21

申请号：US15538902

申请日：2015-12-17

申请人： JIAN LIU , JOSEPH A. KOZLOWSKI , ABDUL-BASIT ALHASSAN , SOBHANA BABU BOGA , XIAOLEI GAO , DEODIAL GUY GUIADEEN , JYHSHING WANG , WENSHENG YU , JIAQIANG CAI , SHILAN LIU , DAHAI WANG , HAO WU , CHUNDAO YANG

发明人： JIAN LIU , JOSEPH A. KOZLOWSKI , ABDUL-BASIT ALHASSAN , SOBHANA BABU BOGA , XIAOLEI GAO , DEODIAL GUY GUIADEEN , JYHSHING WANG , WENSHENG YU , JIAQIANG CAI , SHILAN LIU , DAHAI WANG , HAO WU , CHUNDAO YANG

IPC分类号： C07D487/04 , A61K31/4985 , A61K31/5377 , C07D519/00

CPC分类号： C07D487/04 , A61K31/4985 , A61K31/5377 , A61K45/06 , A61P37/02 , C07D519/00

摘要： The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.